Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients

Background: We aimed to explore the role of mitochondrial aldehyde dehydrogenase 2 (ALDH2) in prostate cancer (PCa) patients and provide insights into the tumor immune microenvironment (TME) for those patients undergoing radical radiotherapy. Methods: We performed all analyses using R version 3.6.3...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Dechao, Zhu, Weizhen, You, Jia, Shi, Xu, Han, Ping, Wei, Wuran, Wei, Qiang, Yang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500792/
https://www.ncbi.nlm.nih.gov/pubmed/36144737
http://dx.doi.org/10.3390/molecules27186000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500792/
https://www.ncbi.nlm.nih.gov/pubmed/36144737
http://dx.doi.org/10.3390/molecules27186000

Ejemplares similares